As of March 23, 2026, BriaCell Therapeutics's top three insider holders are Marc Lustig (Director, 2.54Mn shares), Jamieson Bondarenko (Chairman, 169.86K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Marc Lustig | 0 | 2,542,935 | 20 May, 2024 | |
| Jamieson Bondarenko | Chairman | 169,856 | 0 | 28 Dec, 2022 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 14 May, 2024 | Marc Lustig | Common Shares | A | 902,935 | $2.22 | 2,542,935 | I | P |
| 14 May, 2024 | Marc Lustig | Common Stock Warrants | A | 902,935 | - | 902,935 | I | P |
| 23 Dec, 2022 | William V. Williams | Warrant | A | 2,530 | $1.94 | 29,802 | D | P |
| 28 Dec, 2022 | Jamieson Bondarenko | Common Shares | A | 28,000 | $4.58 | 169,856 | D | P |
| 20 Dec, 2022 | Jamieson Bondarenko | Common Shares | A | 22,000 | $5.35 | 141,856 | D | P |